- Supported exchanges /
- F /
- 698.F
ACHILLES THERAP.SP.ADS/1 (698 F) stock market data APIs
Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.
ACHILLES THERAP.SP.ADS/1 Financial Data Overview
0.87 | |
0.87 | |
- | |
0.87 | |
0.87 | |
0.59-1.43 | |
39 069 K | |
41 088 K | |
0 | |
1.353 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
ACHILLES THERAP.SP.ADS/1 Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -65 899 000
- Earnings Per Share -1.46
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get ACHILLES THERAP.SP.ADS/1 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get ACHILLES THERAP.SP.ADS/1 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: